Pauling AI Blog

Pauling AI Blog

Home
Pauling.AI
Podcast
Archive
Leaderboard
About
Small Molecule Drug Discovery for Longevity: Current Breakthroughs and Clinical Pipeline 2025
By The Pauling.AI Team.
AI Docking vs. Traditional Docking: What the 2025 Benchmarks Really Tell Us
By the Pauling.AI Team
 • Antonella Ballestas and Oleksandr Savytskyi
Computational CROs Won't Survive: How Companies Using AI for Drug Discovery Are Winning!
The multi billion dollar computational chemistry CRO market is collapsing faster than anyone predicted.
 • Antonella Ballestas
DRUG DISCOVERY WITHOUT THE HEADACHE
Too many tools, too little interoperability. Cut through license limits, fragile toolchains, and format clashes. The Pauling.AI workflow takes you from…
 • Oleksandr Savytskyi
IF WET LAB VALIDATION IS ESSENTIAL, WHY USE COMPUTATIONAL METHODS IN DRUG DISCOVERY?
Integrating computational and experimental methods in biology and chemistry accelerates drug discovery, reduces costs, and provides deeper molecular…
 • Oleksandr Savytskyi
One line code change → Save thousands
Benchmarking x86 vs ARM on GCP using a cheminformatics pipeline. One build flag reduced CPU costs by over 50%, with zero changes to application logic.
 • Pablo Villanueva
The new Pauling.AI blog
Here we go
 • Javier Tordable
Pauling AI Blog
Pauling AI Blog
The blog of Pauling.AI, in substack. AI for drug discovery, computational chemistry, techbio and longevity medicine.
Official
Pauling.AI home page
The Pauling Principle Podcast

Pauling AI Blog

AboutArchiveSitemap
© 2026 Pauling.AI · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture